Only human Lyme vaccine in development enters phase 3 trial
Pfizer and French biotech collaborator Valneva have announced the launch of a phase 3 trial for their Lyme disease vaccine. If it is success...
Pfizer and French biotech collaborator Valneva have announced the launch of a phase 3 trial for their Lyme disease vaccine. If it is success...
